PreludeDx

PreludeDx delivers actionable tools to manage early stage breast cancer for patients and their physi

11/05/2026

Less fear. More information. A personalized game plan for DCIS.

In our next Conversations with Hannah Storm, breast surgeon
Dr. Vince Reid of MercyOne Waterloo Breast Center in Iowa, shares how DCISionRT® helps inform discussions about recurrence risk and radiation benefit—and how that information can help patients reconsider treatment choices driven by fear.

“It has taken the guessing game out of it.”

From considering breast-conserving surgery instead of mastectomy to making informed radiation decisions, Dr. Reid explains why personalized information and multidisciplinary collaboration matter.

His description of DCISionRT? “Game changer.”

Watch the full conversation: https://bit.ly/4AkaSNT

11/03/2026

As October comes to a close, remember: every month is Breast Cancer Awareness Month. 💗 The need for information and support continues all year long.

Our partner Learn Look Locate remains a valuable resource for women navigating a DCIS diagnosis, including education about DCISionRT® and how it can help inform personalized radiation treatment decisions.

Revisit these helpful resources:
• Understanding Your Risk After a DCIS Diagnosis
https://bit.ly/4sJEAt8

• Do I Need Radiation If I Have DCIS?
https://bit.ly/4eb7JaC

Keep learning, keep asking questions and share these resources with someone who could benefit.

10/30/2026

Facebook
We’re so close to reaching our Breast Cancer Awareness Month goal!

Nearly 1,300 women are being informed with DCISionRT scores — and every one helps us raise funds for awareness and education.

For each test this month, PreludeDx donates $10 to our advocacy partners. Thank you for helping us make a difference!

Learn more: https://bit.ly/4y0Hcng

10/28/2026

We have data. Let’s use it to personalize care.

For women diagnosed with DCIS, uncertainty can fuel fear—and another person’s breast cancer experience can shape expectations about their own treatment.

In this Conversations with Hannah Storm interview, breast surgeon Julie Margenthaler, MD, of Washington University in St. Louis explains how DCISionRT® provides individualized data about recurrence risk and radiation therapy benefit to help guide treatment conversations.

She shares how that information helped one patient move from wanting an immediate double mastectomy to feeling comfortable choosing lumpectomy—and why a clear, easy-to-understand report makes a difference in shared decision-making.

Her description of DCISionRT’s impact? “Transformative for my practice.”

Watch the full interview: https://bit.ly/47G8DZ1

10/22/2026

Breast Cancer Awareness Month is about raising awareness—and amplifying the voices helping women navigate their care. 💗

We’re proud to celebrate our advocacy partner Jessica Baladad and Feel For Your Life Magazine, which brings breast health advocacy, healthcare policy, and women’s experiences into focus.

Jessica is helping women better understand the issues that shape their care, find their voice, and advocate for themselves.
At PreludeDx, we’re proud to support that mission.

Explore the magazine and share it with someone who could benefit: https://bit.ly/4zQoHU0

10/20/2026

A DCIS diagnosis can bring fear, uncertainty and difficult treatment decisions. For Nathalie Johnson, MD, breast surgeon at Legacy Health in Oregon, helping patients feel empowered starts with education.

“My job is to teach you about everything you have and tell you about all the tools that we have to take care of you and we’re going to make decisions together.”

Speaking with Hannah Storm, Dr. Johnson explains how DCISionRT® helps her discuss a patient’s recurrence risk and benefit from radiation—bringing greater clarity and confidence to decisions about care.

Watch the full interview: https://bit.ly/3UAMBDW

10/06/2026

“I have a test for that.”

When a woman with DCIS is weighing lumpectomy against mastectomy, her concerns about radiation can shape the decision.

In this clip, Brian Czerniecki, MD, PhD, of Moffitt Cancer Center tells Hannah Storm how he uses DCISionRT® results to help patients understand their recurrence risk and benefit from radiation before choosing a path.

Hear how one result can change the conversation. Watch the full interview: https://bit.ly/4hLli18

10/01/2026

Every DCISion makes a difference. 💗

This Breast Cancer Awareness Month, every patient who receives a DCISionRT® test will also help PreludeDx give back.

Throughout October, we will donate $10 for every patient tested.

✨ Our goal: 1,300 tests—and $13,000 for breast cancer advocacy!

Donations will benefit DCIS 411, Survivingbreastcancer.org,
Feel Fit For Your Life, Sharsheret and DCIS-Understood

These organizations are our partners in the fight against breast cancer. Every day, they provide education, advocacy, support and community to help patients feel more informed, empowered and less alone.

Together, 1,300 tests can make an even greater difference. Follow our progress and learn more: https://bit.ly/4y0Hcng

09/28/2026

We’re just two days away from Coverage at a Crossroads.

Join Hannah Storm, physicians and patients for an important conversation about how personalized breast cancer testing informs treatment decisions—and why protecting Medicare access matters.

📅 Thursday, October 1
🕛 12:00–1:00 p.m. ET
💻 Virtual

There’s still time to register. Join the conversation and make a difference: https://bit.ly/4cxGjL4

Sponsored by Women’s Health Advocates, the Breast Cancer Early Detection Coalition and PreludeDx.

09/24/2026

Join us at for a featured Oral Scientific Session highlighting new validation data for AidaBREAST®.

Atif Khan, MD, MS, of Memorial Sloan Kettering Cancer Center will present:

“Validation of a Multi-Omic Biosignature in a Multi-Institutional Cohort to Predict Locoregional Recurrence Risk and Differential RT Effect in Early-Stage Invasive Breast Cancer”

📅 Wednesday, September 30
⏰ 9:55–10:05 a.m.
📍 Room 258
🔬 Scientific Session SS-46

Don’t miss this important presentation exploring how a multi-omic biosignature may help inform more personalized radiation treatment decisions.

Address

26051 Merit Circle Suite 103
Laguna Hills, CA
92653

Website

http://www.preludedx.com/

Alerts

Be the first to know and let us send you an email when PreludeDx posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to PreludeDx:

Show All